Adage Capital Partners Gp, L.L.C. Black Diamond Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$22.23 - $34.75 $5.18 Million - $8.1 Million	-233,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$29.47 - $35.0 $2.59 Million - $3.08 Million	88,000 Added 60.69%	233,000 $7.47 Million
Q3 2020 Nov 16, 2020	BUY	$26.17 - $43.07 $3.79 Million - $6.25 Million	145,000 New	145,000 $4.38 Million

47.6M

2.9K

69.4K

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $68.3M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.